Peripheral/Endo

PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis

PITTSBURGH–(BUSINESS WIRE)–PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, has received an additional CE Mark for its exGraft family of vascular grafts, expanding its on-label use. exGraft vascular grafts are intended for use as vascular prostheses for replacement or bypass of diseased or injured vessels, and with the new clearance, exGraft now includes instructions for post-

Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit

IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA ’24 Emerging Medtech Summit. Scheduled for March 20, 2024, at 10:55 am PT on Track 3, Thompson will offer insights into the company’s innovative portfolio and its impact on vascular disease trea

Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China

WUXI, China, March 7, 2024 /PRNewswire/ — Silk Road Medical (NASDAQ: SILK), a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and…

New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism

SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced clinical data validating the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE). The data was presented during the 2024 AVF (American Venous Forum) by Jacob Shapiro, M.D., vascular surgeon at TriHealth in Cincinnati, OH. The real-world study, “Shorter Time to Assessment and Anticoagulation with Decreased Mortalit

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

HANGZHOU, China, March 7, 2024 /PRNewswire/ — Zylox-Tonbridge (2190.HK, “the Company”), a leading medical device company in the peripheral and neurovascular interventional market in China, today announced a new strategic partnership with Avinger, a commercial-stage medical device company…

La Jolla Vein & Vascular Proudly Announces World Lymphedema Day Patient Education Event

LA JOLLA, Calif.–(BUSINESS WIRE)–La Jolla Vein & Vascular, a leading provider of vascular health services in the San Diego area, is excited to announce their upcoming event today, the World Lymphedema Day Patient Education Event. This informative and educational function is scheduled to take place on March 6, 2024, in the practice lobby of La Jolla Vein & Vascular. Lymphedema, a condition affecting many individuals around the world, is a chronic disorder that can have a significant im